EGLN2 and head and neck squamous cell carcinoma: Still, the TCGA-obtained data suggest a potential negative correlation between transcript levels of EGLN2 and EGLN3 and DNA methylation of their promoter region, as well the impact of this DNA methylation on HNSCC patients’ overall survival.